mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19).
UnitedHealth skips hearing in the wake of Change cyberattack, triggering call for subpoena
In the first federal hearing focused on the massive cyberattack on Change Healthcare, lawmakers had many important questions for UnitedHealth, which owns Change: Did it